20 results
8-K
ARCT
Arcturus Therapeutics Holdings Inc
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
5.05.
Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics.
On December 7, 2021, the Board approved … and adopted a new Code of Business Conduct and Ethics (the “New Code of Conduct”). The New Code of Conduct is applicable to all directors, officers
8-K12B
EX-14.1
ARCT
Arcturus Therapeutics Holdings Inc
14 Jun 19
Notification of registration of securities
5:10pm
Exhibit 14.1
Arcturus Therapeutics Holdings Inc.
Code of Business Conduct and Ethics
Introduction
Ethics are important to Arcturus Therapeutics … to the highest ethical standards and to conducting its business with the highest level of integrity.
The Arcturus Code of Business Conduct and Ethics
8-K
EX-14.1
ARCT
Arcturus Therapeutics Holdings Inc
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
CODE OF BUSINESS CONDUCT AND ETHICS
Policy ID# [ ]
Last Edited: December 6, 2021
Purpose of Policy
Why do we have this Code?
Arcturus … Therapeutics Holdings Inc. (together with its subsidiaries, “Arcturus” or the “Company”) has adopted the Arcturus Code of Business Conduct and Ethics (the “Code
8-K12B
ARCT
Arcturus Therapeutics Holdings Inc
14 Jun 19
Notification of registration of securities
5:10pm
herein by reference.
Item 5.05. Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics.
On June 13, 2019 … , the Company adopted a Code of Business Conduct and Ethics (the “Code”), which applies to all directors, officers and employees of the Company and its
8-K
EX-99.1
ARCT
Arcturus Therapeutics Holdings Inc
10 May 21
Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data
4:21pm
maximum targeted clinical dose
On track to file CTA this quarter for Phase 2 multiple dose study; ethics committee submission completed
ARCT-032
8-K
EX-10.1
allspgf 9bpexozirewr
4 Nov 22
Entry into a Material Definitive Agreement
5:00pm
DEF 14A
icohgq
1 Oct 19
Definitive proxy
6:07am
DEFR14A
ipxr612r582
12 May 22
Revised proxy
5:00pm
10-K
1wkvef qkqt
16 Mar 20
Annual report
11:09am
S-4
pvov2j2rk491
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
S-4/A
69gsl
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
424B3
jpqo53tny54j6hn 7gz
12 Apr 19
Prospectus supplement
4:39pm
- Prev
- 1
- Next